| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Accounting Fees | 2,250 | 1,125 | 1,125 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 8,000 shares IDEXX Laboratories, Inc. | 3,998,960 | 3,998,960 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| 35,629.7920 shares Vanguard Total Stock Market Index | FMV | 6,934,983 | 6,934,983 |
| 817,109.0140 shares Vanguard Short Term Investment Grade Instl Cl | FMV | 9,012,712 | 9,012,712 |
| 89,909.0000 shares Vanguard Intermediate Term Corp Bond ETF | FMV | 8,733,760 | 8,733,760 |
| 61,394.0000 shares Vanguard Long Term Corp Bond ETF | FMV | 6,819,032 | 6,819,032 |
| 3,022.0000 shares Vanguard S&P Small Cap 600 ETF | FMV | 507,001 | 507,001 |
| Description | Amount |
|---|---|
| Net Unrealized Gain on Securities | 2,083,883 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Excise Tax | 573,086 | 0 | 0 |